Trials / Completed
CompletedNCT02764268
Apatinib Dose Titration in Advanced or Metastatic Gastric Cancer
Apatinib Dose Titration: Analyses of Exposure, Safety and Efficacy in Advanced or Metastatic Gastric Cancer
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Apatinib dose titration in Advanced or Metastatic Gastric Cancer
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Apatinib |
Timeline
- Start date
- 2016-11-02
- Primary completion
- 2018-12-10
- Completion
- 2019-04-15
- First posted
- 2016-05-06
- Last updated
- 2022-03-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02764268. Inclusion in this directory is not an endorsement.